Perspective and update: intrapleural fibrinolytic therapy for pleural infections and other forms of pleural organization
Abstract Intrapleural fibrinolytic therapy (IPFT), also known as intrapleural enzymatic therapy (IET), has been utilized for decades to treat pleural infections by expediting drainage in patients with pleural organization. The successful MIST2 trial demonstrated that IPFT improves pleural opacificat...
Saved in:
| Main Authors: | Torry A. Tucker, Andrey A. Komissarov, Steven Idell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Respiratory Research |
| Online Access: | https://doi.org/10.1186/s12931-025-03184-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intrapleural fibrinolytic therapy for pleural infections: Outcomes from a cohort study
by: Glenn Khai Wern Yong, et al.
Published: (2024-12-01) -
Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage
by: Torry A. Tucker, et al.
Published: (2025-07-01) -
Intrapleural Fibrinolytic Therapy in Pediatric Loculated Pleural Effusion: A Case Report
by: Rhea P Gandhi, et al.
Published: (2024-09-01) -
Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
by: Husain Kadhem, et al.
Published: (2021-01-01) -
Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
by: Magdalena Klanova, et al.
Published: (2012-01-01)